BG102949A - Карбапенемови антибактериални съединения, състави, съдържащи такива съединения и методи за лечение - Google Patents

Карбапенемови антибактериални съединения, състави, съдържащи такива съединения и методи за лечение Download PDF

Info

Publication number
BG102949A
BG102949A BG102949A BG10294998A BG102949A BG 102949 A BG102949 A BG 102949A BG 102949 A BG102949 A BG 102949A BG 10294998 A BG10294998 A BG 10294998A BG 102949 A BG102949 A BG 102949A
Authority
BG
Bulgaria
Prior art keywords
groups
substituted
alkyl
straight
group
Prior art date
Application number
BG102949A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert WILKENING
Ronald RATCLIFFE
Timothy BLIZZARD
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG102949A publication Critical patent/BG102949A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG102949A 1996-04-24 1998-11-23 Карбапенемови антибактериални съединения, състави, съдържащи такива съединения и методи за лечение BG102949A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
PCT/US1997/006626 WO1997040048A1 (en) 1996-04-24 1997-04-21 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Publications (1)

Publication Number Publication Date
BG102949A true BG102949A (bg) 1999-10-29

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102949A BG102949A (bg) 1996-04-24 1998-11-23 Карбапенемови антибактериални съединения, състави, съдържащи такива съединения и методи за лечение

Country Status (31)

Country Link
EP (1) EP0906313B1 (zh)
JP (1) JP3176068B2 (zh)
KR (1) KR20000010599A (zh)
CN (1) CN1074767C (zh)
AR (1) AR006810A1 (zh)
AT (1) ATE260915T1 (zh)
AU (1) AU707459B2 (zh)
BG (1) BG102949A (zh)
BR (1) BR9708864A (zh)
CA (1) CA2252402C (zh)
CO (1) CO4990968A1 (zh)
CZ (1) CZ340798A3 (zh)
DE (1) DE69727931T2 (zh)
EA (1) EA001296B1 (zh)
EE (1) EE03689B1 (zh)
ES (1) ES2216142T3 (zh)
HK (1) HK1021186A1 (zh)
HR (1) HRP970213A2 (zh)
HU (1) HUP9901778A3 (zh)
ID (1) ID16662A (zh)
IL (1) IL126480A0 (zh)
IS (1) IS4861A (zh)
NO (1) NO984949L (zh)
NZ (1) NZ332183A (zh)
PE (1) PE64298A1 (zh)
PL (1) PL186881B1 (zh)
SK (1) SK283550B6 (zh)
TR (1) TR199802140T2 (zh)
TW (1) TW539677B (zh)
WO (1) WO1997040048A1 (zh)
YU (1) YU46298A (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
CA2287931A1 (en) * 1997-05-13 1998-11-19 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
DE69813870T2 (de) * 1997-10-23 2004-02-05 Merck & Co., Inc. Antibakterielle carbapenem-verbindungen, zusammensetzungen, die diese verbindungen enthalten und behandlungsmethoden
JP2002509856A (ja) * 1997-10-23 2002-04-02 メルク エンド カムパニー インコーポレーテッド カルバペネム系抗菌化合物、組成物および治療方法
US6140318A (en) 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
EP1104424B1 (en) * 1998-06-17 2004-04-07 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates
US6265395B1 (en) * 1998-06-25 2001-07-24 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2335571A1 (en) * 1998-06-25 1999-12-29 Merck & Co. Inc. (heterocyclic) methyl substituted carbapenem antibacterials
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
HRP970213A2 (en) 1998-06-30
HK1021186A1 (en) 2000-06-02
SK145498A3 (en) 1999-10-08
EA199800949A1 (ru) 1999-04-29
DE69727931T2 (de) 2005-04-14
PE64298A1 (es) 1998-10-30
EP0906313B1 (en) 2004-03-03
SK283550B6 (sk) 2003-09-11
AU707459B2 (en) 1999-07-08
NO984949L (no) 1998-12-21
EP0906313A1 (en) 1999-04-07
IS4861A (is) 1998-10-06
JP3176068B2 (ja) 2001-06-11
AR006810A1 (es) 1999-09-29
ID16662A (id) 1997-10-30
PL186881B1 (pl) 2004-03-31
ES2216142T3 (es) 2004-10-16
ATE260915T1 (de) 2004-03-15
TW539677B (en) 2003-07-01
HUP9901778A3 (en) 2000-06-28
CA2252402A1 (en) 1997-10-30
NZ332183A (en) 2000-05-26
EA001296B1 (ru) 2000-12-25
WO1997040048A1 (en) 1997-10-30
PL329376A1 (en) 1999-03-29
JPH11508279A (ja) 1999-07-21
CN1074767C (zh) 2001-11-14
CN1222912A (zh) 1999-07-14
CA2252402C (en) 2002-12-24
EE9800355A (et) 1999-04-15
EE03689B1 (et) 2002-04-15
AU2462997A (en) 1997-11-12
CO4990968A1 (es) 2000-12-26
HUP9901778A2 (hu) 1999-09-28
DE69727931D1 (de) 2004-04-08
IL126480A0 (en) 1999-08-17
YU46298A (sh) 2000-03-21
KR20000010599A (ko) 2000-02-15
NO984949D0 (no) 1998-10-23
TR199802140T2 (xx) 1999-01-18
BR9708864A (pt) 1999-08-03
CZ340798A3 (cs) 1999-03-17

Similar Documents

Publication Publication Date Title
BG102949A (bg) Карбапенемови антибактериални съединения, състави, съдържащи такива съединения и методи за лечение
AU9223698A (en) 3-(iodophenoxymethyl) carbapenem antibacterials
AU4184497A (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6291448B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment
CA2335510A1 (en) Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
US6294528B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment
US6265395B1 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU4490597A (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU1082499A (en) Antibacterial carbapenems, compositions and methods of treatment
CA2298997A1 (en) Carbapenems with naphthosultam derivative linked via methylene
JP2001519352A (ja) カルバペネム系抗菌化合物、該化合物を含有する組成物および治療方法
JP2002518496A (ja) (複素環)メチル置換カルバペネムカルバペネム抗細菌物質